Arkolith/Insider Trading/AIDX/Form 4

Rollins John Woodson

Director20/20 Biolabs, Inc. (AIDX) · full profile →Form 4 · filed Feb 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 19, 2026Conversion(C)13K—$024K
Feb 19, 2026Conversion(C)6K—$030K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 19, 2026Conversion(C)13K——0
Feb 19, 2026Conversion(C)6K——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-019456) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML